Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial
Swiss National Science Foundation under the framework of Neuron Cofund, Swiss Neuromatrix Foundation, and Heffter Young Investigator Fellowship Award.
Authors
- Marcus Herdener (ORCID: https://orcid.org/0000-0001-5830-1971)
- Etna Engeli (ORCID: https://orcid.org/0000-0001-7176-8728)
- Raoul Bitar
- Simon Halm
- Carlos Nordt (ORCID: https://orcid.org/0000-0002-1156-152X)
- Flora Moujaes (ORCID: https://orcid.org/0000-0002-0843-0393)
- Katrin H. Preller (ORCID: https://orcid.org/0000-0003-0413-7672)
- Erich Seifritz (ORCID: https://orcid.org/0000-0002-7311-4426)
- Nathalie M. Rieser (ORCID: https://orcid.org/0000-0002-5804-1409)
- Ladina P Gubser
- Robin von Rotz (ORCID: https://orcid.org/0000-0003-4087-3650)
- Monika Visentini
- Christina Rossgoderer
- Franz X. Vollenweider (ORCID: https://orcid.org/0000-0001-9053-6164)
- Andres Ort
- Yara Kreis
- Maeva Thévenaz
Institutions
- University of Zurich (CH)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103149
- Citations
- 28
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 64.59